Management of bone tumours in paediatric oncology.
The management of bone tumours in paediatric oncology requires careful multidisciplinary planning due to the need for multimodal therapy approaches. The non-specific symptoms often lead to a delayed definitive diagnosis of a bone tumour. Imaging procedures are of major importance for an individualised and optimised treatment planning. They have to be carried out before any surgery, including biopsies. The introduction of multi-agent chemotherapy has led to a significant improvement in survival rates in patients suffering from Ewing's sarcomas and osteosarcomas. However, local therapy still remains indispensable in order to achieve long-term survival. For osteosarcoma, surgery remains the only adequate local therapy modality. Radiotherapy may be considered if surgery is not feasible. In these cases, high radiation doses need to be applied. The choice for local therapy modality is not as clear in patients with Ewing's sarcoma. Today, surgery is often preferred if a wide or at least marginal resection can be carried out. Additional radiotherapy is advised in patients with marginal/intralesional resection or poor histological response to induction chemotherapy. Definitive radiotherapy is recommended for inoperable lesions. In the future, new radiotherapy approaches, such as intensity-modulated radiotherapy or proton therapy, may yield better results with minor risks of late effects.
Department of Radiotherapy and Radiation Oncology, University Hospital of Münster, Münster, Germany. Tobias.Boelling@uni-muenster.de
T
T
Bölling
J
J
Hardes
U
U
Dirksen
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000532:radiotherapy*; D002648:Child; D003131:Combined Modality Therapy; D019468:Disease Management; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D012516:Osteosarcoma / Q000628:therapy; D050397:Radiotherapy, Intensity-Modulated; D012512:Sarcoma, Ewing / Q000628:therapy